Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection

Production and purification of an untagged recombinant pneumococcal surface protein A (PspA4Pro) with high-purity and low endotoxin content

(2016) Douglas B. Figueiredo et al.   APPLIED MICROBIOLOGY AND BIOTECHNOLOGY

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

(2016) Haidong Wang et al.   LANCET

Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection

(2016) Y Wang et al.   Mucosal Immunology

Pulmonary dry powder vaccine of pneumococcal antigen loaded nanoparticles

(2015) Nitesh K. Kunda et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques

(2015) Y Fukuyama et al.   Mucosal Immunology

A Randomized, Controlled Trial of an Aerosolized Vaccine against Measles

(2015) Nicola Low et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults

(2015) Marc J.M. Bonten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings

(2015)   VACCINE

Influences of process and formulation parameters on powder flow properties and immunogenicity of spray dried polymer particles entrapping recombinant pneumococcal surface protein A

(2014) Chakkumkal Anish et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Retention of structure, antigenicity, and biological function of pneumococcal surface protein A (PspA) released from polyanhydride nanoparticles

(2013) Shannon L. Haughney et al.   Acta Biomaterialia

Nanogel-Based PspA Intranasal Vaccine Prevents Invasive Disease and Nasal Colonization by Streptococcus pneumoniae

(2013) Il Gyu Kong et al.   INFECTION AND IMMUNITY

Harnessing local and systemic immunity for vaccines against tuberculosis

(2013) P C L Beverley et al.   Mucosal Immunology

TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines

(2013) Anneliese S. Tyne et al.   VACCINE

Controlled Inflammatory Responses in the Lungs Are Associated with Protection Elicited by a Pneumococcal Surface Protein A-Based Vaccine against a Lethal Respiratory Challenge with Streptococcus pneumoniae in Mice

(2012) Fernanda A. Lima et al.   Clinical and Vaccine Immunology

Nanocarriers Targeting Dendritic Cells for Pulmonary Vaccine Delivery

(2012) Nitesh K. Kunda et al.   PHARMACEUTICAL RESEARCH

Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis

(2011) Marie Ballester et al.   VACCINE

Immunization of Mice with Single PspA Fragments Induces Antibodies Capable of Mediating Complement Deposition on Different Pneumococcal Strains and Cross-Protection

(2010) A. T. Moreno et al.   Clinical and Vaccine Immunology

Needle-free influenza vaccination

(2010) Jean-Pierre Amorij et al.   LANCET INFECTIOUS DISEASES

Combination of Pneumococcal Surface Protein A (PspA) with Whole Cell Pertussis Vaccine Increases Protection Against Pneumococcal Challenge in Mice

(2010) Maria Leonor S. Oliveira et al.   PLoS One

Inhaled delivery of 23-valent pneumococcal polysaccharide vaccine does not result in enhanced pulmonary mucosal immunoglobulin responses

(2008) Stephen B. Gordon et al.   VACCINE